PDCD1 and intrahepatic cholangiocarcinoma: Two clinical trials by Zhou et al. and Li et al. confirmed the efficacy of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy in ICC or BTC [16, 17].